DECOR Information for Project: HL7 Italia specifiche per l’implementazione (hl7itig-)

Identifiers

As for now used for rendering purposes only.

v3.ActPriority 2.16.840.1.113883.1.11.16866

Language Display Name Description
it-IT v3.ActPriority v3.ActPriority

TNM Edition8 UICC 2.16.840.1.113883.15.16

Language Display Name Description
it-IT TNM Edition8 UICC TNM Edition8 UICC

hl7itig-valueset-16 2.16.840.1.113883.3.1937.777.63.11.16

Language Display Name Description
it-IT hl7itig-valueset-16 hl7itig-valueset-16

hl7itig-valueset-25 2.16.840.1.113883.3.1937.777.63.11.25

Language Display Name Description
it-IT hl7itig-valueset-25 hl7itig-valueset-25

hl7itig-valueset-26 2.16.840.1.113883.3.1937.777.63.11.26

Language Display Name Description
it-IT hl7itig-valueset-26 hl7itig-valueset-26

AdministrativeGender 2.16.840.1.113883.5.1

Language Display Name Description
it-IT AdministrativeGender AdministrativeGender

HL7ActRelationshipType 2.16.840.1.113883.5.1002

Language Display Name Description
it-IT HL7ActRelationshipType HL7ActRelationshipType

RoleStatus 2.16.840.1.113883.5.1068

Language Display Name Description
it-IT RoleStatus RoleStatus

AddressUse 2.16.840.1.113883.5.1119

Language Display Name Description
it-IT AddressUse AddressUse

ActStatus 2.16.840.1.113883.5.14

Language Display Name Description
it-IT ActStatus ActStatus

BasicConfidentialityKind 2.16.840.1.113883.5.25

Language Display Name Description
it-IT BasicConfidentialityKind BasicConfidentialityKind

Act Code 2.16.840.1.113883.5.4

Language Display Name Description
it-IT Act Code Act Code

ParticipationFunction 2.16.840.1.113883.5.88

Language Display Name Description
it-IT ParticipationFunction ParticipationFunction

LOINC 2.16.840.1.113883.6.1

Language Display Name Description
it-IT LOINC LOINC

ICD-9-CM 2.16.840.1.113883.6.103

Language Display Name Description
it-IT ICD-9-CM ICD-9-CM

List of Template Identifiers used in this project

Id Display Name Effective date Type
2.16.840.1.113883.2.9.10.1.2.1 Prescrizione Farmaceutica (PrF) cdadocumentlevel
hl7itig-template-111 Messaggio Regionale_v2 (Pr) cdasectionlevel
hl7itig-template-18 CDA recordTarget cdaheaderlevel
hl7itig-template-239 CDA Organization cdaheaderlevel cdaentrylevel
hl7itig-template-263 Parametri Vitali Pr cdasectionlevel
hl7itig-template-265 AllergieIntolleranze_Pr cdaentrylevel
hl7itig-template-27 Esenzioni (PrF) cdasectionlevel
hl7itig-template-270 StatoDelPaziente_Pr cdaentrylevel
hl7itig-template-34 CDA addr cdaheaderlevel
hl7itig-template-36 CDA AssignedEntity cdaheaderlevel cdaentrylevel
hl7itig-template-39 CDA author(Pr) cdaheaderlevel
hl7itig-template-41 CDA custodian (Pr) cdaheaderlevel
hl7itig-template-42 CDA legalAuthenticator (Pr) cdaheaderlevel
hl7itig-template-54 CDA person cdaheaderlevel
hl7itig-template-58 CDA Organization cdaheaderlevel
hl7itig-template-59 CDA organizationPartOf cdaheaderlevel
hl7itig-template-60 CDA name cdaheaderlevel
hl7itig-template-61 CDA person (Pr) cdaheaderlevel
hl7itig-template-62 CDA authenticator (Pr) cdaheaderlevel
hl7itig-template-63 CDA participant (Pr) cdaheaderlevel
hl7itig-template-64 CDA dataEnterer (Pr) cdaheaderlevel
hl7itig-template-66 CDA relatedDocument (Pr) cdaheaderlevel
hl7itig-template-71 Annotazioni (PrF) cdasectionlevel
hl7itig-template-76 Prescrizioni (PrF) cdasectionlevel
hl7itig-template-77 Prescrizione farmeceutica (PrF) cdaentrylevel
hl7itig-template-85 CDA componentOf (PrF) cdaheaderlevel
hl7itig-template-89 Esenzioni Applicate (Pr) cdaentrylevel
hl7itig-template-91 Elemento30/Note Generali (Pr) cdaentrylevel

List of Value Set Identifiers used in this project

Id Display Name Effective date
2.16.840.1.113883.5.1119 AddressUse
2.16.840.1.113883.1.11.1 AdministrativeGender
hl7itig-valueset-26 Farmaco non sostituibile
hl7itig-valueset-14 Motivazioni di non sostituibilità
2.16.840.1.113883.1.11.10267 ParticipationFunction
hl7itig-valueset-12 RoleCodeIT
2.16.840.1.113883.1.11.15999 RoleStatus
2.16.840.1.113883.1.11.11610 x_ActRelationshipDocument

Data sets, codes, OIDs and Rules: this information is used for rendering and validation purposes.